ADORA2A and Parkinson disease: A2AR antagonists confer neuroprotection in animal models of stroke, Parkinson’s and Alzheimer’s disease, and traumatic brain injury, most likely by controlling neuroinflammation, excitotoxic neuronal damage, and synaptopathy [20,21].